000 | 01949 a2200529 4500 | ||
---|---|---|---|
005 | 20250515034143.0 | ||
264 | 0 | _c20061128 | |
008 | 200611s 0 0 eng d | ||
022 | _a0360-4012 | ||
024 | 7 |
_a10.1002/jnr.20999 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTian, Dai-Shi | |
245 | 0 | 0 |
_aSuppression of astroglial scar formation and enhanced axonal regeneration associated with functional recovery in a spinal cord injury rat model by the cell cycle inhibitor olomoucine. _h[electronic resource] |
260 |
_bJournal of neuroscience research _cOct 2006 |
||
300 |
_a1053-63 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAstrocytes _xdrug effects |
650 | 0 | 4 | _aBehavior, Animal |
650 | 0 | 4 |
_aBlotting, Western _xmethods |
650 | 0 | 4 |
_aCell Count _xmethods |
650 | 0 | 4 |
_aCell Cycle Proteins _xgenetics |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aCicatrix _xdrug therapy |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aEnzyme Inhibitors _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aImmunohistochemistry _xmethods |
650 | 0 | 4 |
_aIn Situ Nick-End Labeling _xmethods |
650 | 0 | 4 |
_aKinetin _xtherapeutic use |
650 | 0 | 4 |
_aNerve Regeneration _xdrug effects |
650 | 0 | 4 |
_aNerve Tissue Proteins _xmetabolism |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aRecovery of Function _xdrug effects |
650 | 0 | 4 |
_aSpinal Cord Injuries _xdrug therapy |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
700 | 1 | _aYu, Zhi-Yuan | |
700 | 1 | _aXie, Min-Jie | |
700 | 1 | _aBu, Bi-Tao | |
700 | 1 | _aWitte, Otto W | |
700 | 1 | _aWang, Wei | |
773 | 0 |
_tJournal of neuroscience research _gvol. 84 _gno. 5 _gp. 1053-63 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/jnr.20999 _zAvailable from publisher's website |
999 |
_c16452355 _d16452355 |